Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Thomas Roche had five children and his family said he had had a head injury days before he went missing A body has been found as police search for a man who has been missing for more than three ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Make space on your beauty counter! Here’s our expert-approved list of the best makeup, skincare and haircare dupes in the ...

THE peso started the week on the wrong foot and the stock market also hit an over 7-month low, with investors said to be waiting for the results of a US Federal Reserve policy meeting and the release ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

After hours: 7:17:13 p.m. EST ...

Conventional vaccinations and immunotherapies have encountered major roadblocks in preventing infectious diseases like HIV, influenza, and malaria. These challenges are due to the high genomic ...

supplemented with protease inhibitor cocktail (Roche) and phosphatase inhibitors (PhoStop; Roche) (Hyrskyluoto et al., 2014; Mäkelä et al., 2016a). Equal amounts of protein were subjected to SDS-PAGE ...

A couple of weeks ago, we tested the Sony A6600, which is the company's latest flagship APS-C mirrorless camera. Now, it's time to take a closer look at the A6100, which is its entry-level sibling.